Form 4 Filing for Anixa Biosciences Inc.

Lewis H. Titterton Jr., a director at Anixa Biosciences Inc., acquired 49,036 shares of common stock on September 23, 2026. The transaction was made at a price of $2.69 per share. Following this acquisition, Titterton Jr. now owns 1,046,003 shares of common stock. This filing is a Form 4, indicating a change in beneficial ownership of securities.